Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Genomic Determinants of Protein Abundance Variation in Colorectal Cancer Cells.

Roumeliotis TI, Williams SP, Gonçalves E, Alsinet C, Del Castillo Velasco-Herrera M, Aben N, Ghavidel FZ, Michaut M, Schubert M, Price S, Wright JC, Yu L, Yang M, Dienstmann R, Guinney J, Beltrao P, Brazma A, Pardo M, Stegle O, Adams DJ, Wessels L, Saez-Rodriguez J, McDermott U, Choudhary JS.

Cell Rep. 2017 Aug 29;20(9):2201-2214. doi: 10.1016/j.celrep.2017.08.010.

2.

Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity.

Wang J, Mouradov D, Wang X, Jorissen RN, Chambers MC, Zimmerman LJ, Vasaikar S, Love CG, Li S, Lowes K, Leuchowius KJ, Jousset H, Weinstock J, Yau C, Mariadason J, Shi Z, Ban Y, Chen X, Coffey RJC, Slebos RJC, Burgess AW, Liebler DC, Zhang B, Sieber OM.

Gastroenterology. 2017 Oct;153(4):1082-1095. doi: 10.1053/j.gastro.2017.06.008. Epub 2017 Jun 16.

3.

Expression profiling of more than 3500 proteins of MSS-type colorectal cancer by stable isotope labeling and mass spectrometry.

Kang UB, Yeom J, Kim HJ, Kim H, Lee C.

J Proteomics. 2012 Jun 6;75(10):3050-62. doi: 10.1016/j.jprot.2011.11.021. Epub 2011 Nov 26.

PMID:
22154799
4.

Identification of Phosphorylated Cyclin-Dependent Kinase 1 Associated with Colorectal Cancer Survival Using Label-Free Quantitative Analyses.

Lin PC, Yang YF, Tyan YC, Hsiao ES, Chu PC, Lee CT, Lee JC, Chen YM, Liao PC.

PLoS One. 2016 Jul 6;11(7):e0158844. doi: 10.1371/journal.pone.0158844. eCollection 2016.

5.

Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project.

Shiromizu T, Adachi J, Watanabe S, Murakami T, Kuga T, Muraoka S, Tomonaga T.

J Proteome Res. 2013 Jun 7;12(6):2414-21. doi: 10.1021/pr300825v. Epub 2013 Jan 11.

PMID:
23312004
6.

Impact of TGF-b on breast cancer from a quantitative proteomic analysis.

Ahn J, Yoon Y, Yeu Y, Lee H, Park S.

Comput Biol Med. 2013 Dec;43(12):2096-102. doi: 10.1016/j.compbiomed.2013.09.022. Epub 2013 Oct 3.

PMID:
24290926
7.

Identification of anti-metastatic drug and natural compound targets in isogenic colorectal cancer cells.

Lee JG, McKinney KQ, Pavlopoulos AJ, Park JH, Hwang S.

J Proteomics. 2015 Jan 15;113:326-36. doi: 10.1016/j.jprot.2014.10.009. Epub 2014 Oct 23.

PMID:
25451013
8.

The genomic landscape of response to EGFR blockade in colorectal cancer.

Bertotti A, Papp E, Jones S, Adleff V, Anagnostou V, Lupo B, Sausen M, Phallen J, Hruban CA, Tokheim C, Niknafs N, Nesselbush M, Lytle K, Sassi F, Cottino F, Migliardi G, Zanella ER, Ribero D, Russolillo N, Mellano A, Muratore A, Paraluppi G, Salizzoni M, Marsoni S, Kragh M, Lantto J, Cassingena A, Li QK, Karchin R, Scharpf R, Sartore-Bianchi A, Siena S, Diaz LA Jr, Trusolino L, Velculescu VE.

Nature. 2015 Oct 8;526(7572):263-7. doi: 10.1038/nature14969. Epub 2015 Sep 30.

9.

Circulating pEGFR is a candidate response biomarker of cetuximab therapy in colorectal cancer.

Katsila T, Juliachs M, Gregori J, Macarulla T, Villarreal L, Bardelli A, Torrance C, Elez E, Tabernero J, Villanueva J.

Clin Cancer Res. 2014 Dec 15;20(24):6346-56. doi: 10.1158/1078-0432.CCR-14-0361. Epub 2014 Oct 16.

10.

Pancancer modelling predicts the context-specific impact of somatic mutations on transcriptional programs.

Osmanbeyoglu HU, Toska E, Chan C, Baselga J, Leslie CS.

Nat Commun. 2017 Jan 31;8:14249. doi: 10.1038/ncomms14249.

11.

Quantitative phospho-proteomic profiling of hepatocyte growth factor (HGF)-MET signaling in colorectal cancer.

Organ SL, Tong J, Taylor P, St-Germain JR, Navab R, Moran MF, Tsao MS.

J Proteome Res. 2011 Jul 1;10(7):3200-11. doi: 10.1021/pr200238t. Epub 2011 Jun 9.

PMID:
21609022
12.

Mapping the Spatial Proteome of Metastatic Cells in Colorectal Cancer.

Mendes M, Peláez-García A, López-Lucendo M, Bartolomé RA, Calviño E, Barderas R, Casal JI.

Proteomics. 2017 Oct;17(19). doi: 10.1002/pmic.201700094.

PMID:
28861940
13.

Stage-specific alterations of the genome, transcriptome, and proteome during colorectal carcinogenesis.

Habermann JK, Paulsen U, Roblick UJ, Upender MB, McShane LM, Korn EL, Wangsa D, Krüger S, Duchrow M, Bruch HP, Auer G, Ried T.

Genes Chromosomes Cancer. 2007 Jan;46(1):10-26.

PMID:
17044061
14.

Modeling RAS phenotype in colorectal cancer uncovers novel molecular traits of RAS dependency and improves prediction of response to targeted agents in patients.

Guinney J, Ferté C, Dry J, McEwen R, Manceau G, Kao KJ, Chang KM, Bendtsen C, Hudson K, Huang E, Dougherty B, Ducreux M, Soria JC, Friend S, Derry J, Laurent-Puig P.

Clin Cancer Res. 2014 Jan 1;20(1):265-272. doi: 10.1158/1078-0432.CCR-13-1943. Epub 2013 Oct 29.

15.

A bioinformatics workflow for variant peptide detection in shotgun proteomics.

Li J, Su Z, Ma ZQ, Slebos RJ, Halvey P, Tabb DL, Liebler DC, Pao W, Zhang B.

Mol Cell Proteomics. 2011 May;10(5):M110.006536. doi: 10.1074/mcp.M110.006536. Epub 2011 Mar 9.

16.

Establishment and characterization of cell lines from chromosomal instable colorectal cancer.

Maletzki C, Gock M, Randow M, Klar E, Huehns M, Prall F, Linnebacher M.

World J Gastroenterol. 2015 Jan 7;21(1):164-76. doi: 10.3748/wjg.v21.i1.164.

17.

Feasibility of label-free phosphoproteomics and application to base-line signaling of colorectal cancer cell lines.

Piersma SR, Knol JC, de Reus I, Labots M, Sampadi BK, Pham TV, Ishihama Y, Verheul HM, Jimenez CR.

J Proteomics. 2015 Sep 8;127(Pt B):247-58. doi: 10.1016/j.jprot.2015.03.019. Epub 2015 Apr 1.

PMID:
25841592
18.

Quantitative phosphoproteomic profiling of human non-small cell lung cancer tumors.

Schweppe DK, Rigas JR, Gerber SA.

J Proteomics. 2013 Oct 8;91:286-96. doi: 10.1016/j.jprot.2013.07.023. Epub 2013 Aug 2.

19.

Subnuclear proteomics in colorectal cancer: identification of proteins enriched in the nuclear matrix fraction and regulation in adenoma to carcinoma progression.

Albrethsen J, Knol JC, Piersma SR, Pham TV, de Wit M, Mongera S, Carvalho B, Verheul HM, Fijneman RJ, Meijer GA, Jimenez CR.

Mol Cell Proteomics. 2010 May;9(5):988-1005. doi: 10.1074/mcp.M900546-MCP200. Epub 2010 Jan 20.

20.

Proteomic consequences of a single gene mutation in a colorectal cancer model.

Halvey PJ, Zhang B, Coffey RJ, Liebler DC, Slebos RJ.

J Proteome Res. 2012 Feb 3;11(2):1184-95. doi: 10.1021/pr2009109. Epub 2011 Dec 13.

Supplemental Content

Support Center